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Abstract
The interactions of carbonmonoxyhemoglobin (HbCO), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and polyhistidine with
phospholipid monolayers at the air–water interface were studied at physiological pH and ionic strength. HbCO and GAPDH both interact
more strongly with monolayers containing negatively charged lipids. The interaction of HbCO and GAPDH with lipid monolayers decreases
with increasing pH. Both the HbCO–monolayer and the GAPDH–monolayer interactions can be modeled as diffusion-limited processes,
with kinetic data fit to a stretched exponential equation. The significance of these kinetics are discussed. Polyhistidine interacts only with
monolayers containing lipids with negatively charged headgroups. In total, the results presented are consistent with an HbCO–lipid
interaction with a large electrostatic component, a GAPDH–lipid interaction with comparable electrostatic and hydrophobic components, and
a polyhistidine– lipid interaction that is solely electrostatic. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Hemoglobin (Hb) and glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) have important roles in oxygen trans-
port and glycolysis, respectively. Both of these proteins have
been reported to bind to lipid monolayers (see Ref. [1] for a
review). In this study the interactions of these proteins with
lipid monolayers at the air–water interface are examined.
GAPDH in particular has been implicated in the main-
tenance of erythrocyte shape [2]. Addition of exogenous
amphipaths can induce shape changes in erythrocytes, as
described by the bilayer couple hypothesis [3]. In membrane
systems with lipid asymmetry, such as the human erythro-
cyte [4], molecules that preferentially intercalate in the
inner/outer monolayer of the membrane increase the inner/
outer surface area of the membrane and cause an inward/
outward buckling of the membrane. The postulated role of
GAPDH in erythrocyte shape control is as an inner mono-
layer intercalator to counteract exogenous outer monolayer
intercalators. GAPDH, with dual roles of glycolysis and
shape control, is an example of a moonlighting protein.
Many examples of moonlighting proteins have been dis-
covered [5,6]. This study examines the GAPDH–lipid
interaction.
Traditionally proteins have been thought of either as
globular and soluble or membrane-bound and insoluble.
This study will show that even nominally soluble, cytosolic
proteins, like Hb and GAPDH, can interact with lipid
monolayers and thus cell membranes. At times, the inter-
action between cytosolic proteins and lipids is strong and
may have a physiological role.
The interaction of polyhistidine with lipid monolayers is
also examined. Histidine-rich proteins may be involved in
the fusion of infectious organisms with mammalian cells.
For example, the malaria parasite produces a histidine-rich
protein (although inoculation of hosts with this histidine-
rich protein confers protection from malarial infection) [7].
The present studies use surface pressure measurements of
phospholipid monolayers at the air–water interface in the
presence of protein [carbonmonoxyhemoglobin (HbCO),
GAPDH, or polyhistidine] in the subphase. The lipid
monolayer at the air–water interface serves as a model for
half of a cell membrane and the subphase can be held at
physiological conditions of pH and ionic strength. A wide
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variety of lipids and proteins can be examined. These
features make monolayer studies a powerful tool in under-
standing protein–lipid interactions.
2. Materials and methods
HbCO was prepared following the method described by
Moxness [8]. Carbon monoxide was bubbled through
blood drawn from healthy human volunteers. After carbon-
monoxylation, the blood cells were washed and lysed and
the cell debris removed by centrifugation. The resulting
supernatant was dialyzed against column buffer (50 mM
Tris, pH 8.3) and purified on an anion exchange column
(DEAE Sephadex A-50). A buffered pH gradient (pH 8.3
to pH 7.0) was run through the column. Fractions con-
taining HbCO were combined and concentrated by ultra-
filtration. Final concentration was approximately 10 mM
in heme (2.5 mM protein). After ultrafiltration the meth-
emoglobin concentration was less than 2% of total Hb
concentration, as determined by multicomponent UV–Vis
analysis. HbCO aliquots (300 Al each) were stored in
liquid nitrogen. HbCO was injected at a final concentration
of 167 nM protein, equivalent to 667 nM in heme, ap-
proximating the physiological lipid/heme ratio in erythro-
cytes. GAPDH (lyophilized, from rabbit muscle) was from
Sigma Chemical Co. (St. Louis, MO). Purity of GAPDH
was checked by SDS-PAGE and activity was confirmed by
colorimetric assay [9]. GAPDH stock solutions were pre-
pared by dissolving GAPDH in buffer [5 mM phosphate or
phosphate-buffered saline (PBS)] and adjusting the pH.
Poly-L-histidine (polyhistidine) was from Sigma and had
an average molecular weight of 15,800. Polyhistidine stock
solutions were prepared by dissolving polyhistidine in
nanopure water. Protein was added to the subphase either
by pre-mixing prior to monolayer formation or by injection
beneath the monolayer without mixing. Pre-mixing was
used in short timescale (less than 15 min) experiments,
while injection was used in longer timescale (several
hours) experiments. For injection experiments, monolayer
surface pressure was allowed to stabilize before addition of
protein (approximately 1 min).
Lipids [dimyristoylethylphosphatidylcholine (DMetPC),
dimyristoylphosphatidylcholine (DMPC), dimyristoylphos-
phatidylglycerol (DMPG), dimyristoylphosphatidylserine
(DMPS, Avanti Polar Lipids, Alabaster, AL), and dihydro-
cholesterol (Dchol, Sigma)] were dissolved in chloroform.
Phospholipids were chosen to have approximately the same
chain length and to be in a liquid phase at the surface
pressures studied. For binary lipids mixtures (DMPC/
DMPS, DMPC/DMPG, DMPC/DMetPC), the molar ratio
was 1:1. Total lipid concentrations in these stock solutions
were approximately 2 mg/ml. Stock solutions of lipids were
diluted 10:1 before deposition on the air–water surface of a
homebuilt teflon Langmuir trough, which was cleaned with
chloroform and rinsed with water after each experiment.
Monolayer surface pressure at room temperature (21 jC)
was measured by a Wilhelmy plate of filter paper [10] and
recorded on a chart recorder. Surface pressure values begin
at 0 mN/m for a bare air–water interface and increase to a
maximum of 72 mN/m. Lipids were added until an initial
monolayer pressure of approximately 1 mN/m was obtained.
Although 1 mN/m is too low for the lipids to structurally
mimic a cell membrane, the primary goal of these experi-
ments was to measure the effect of lipid charge on surface
activity of the proteins. Fits of the data were performed
using KaleidaGraph 3.0 software.
Solution viscosity was adjusted by addition of dextran
(dextran T-70, average molecular weight 70,000). Viscos-
ities were measured in a Cannon-Fenske viscometer (no.
100 size) according to the method of Shoemaker et al. [11–
13]. Aqueous dextran solutions with pHV 7.0 (below the pI
of Hb) were used without additional buffering.
3. Results
3.1. HbCO shows increased surface activity in the presence
of anionic lipids
Since HbCO is a charged protein, it is reasonable to
expect that its surface activity is affected by the charge of
the lipids in the monolayer. Even in the absence of lipids,
injection of HbCO into the aqueous subphase of the trough
produces an increase in surface pressure from 0 to 22 mN/m,
as seen in Fig. 1. In the presence of neutral lipids only
(DMPC), injecting HbCO caused the surface pressure to
increase at a similar rate from 2 to 26 mN/m (Dp, 24 mN/
m). In the presence of cationic lipids (DMPC/DMetPC),
HbCO injection resulted in a slower increase in surface
Fig. 1. Monolayer pressure, p, vs. time, HbCO injected into water subphase
(final protein concentration 167 nM). Data are for different monolayer
compositions: ( ) DMPC/DMPS; (+) DMPC; ( w ) DMPC/DMetPC; (5)
no lipids present.
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pressure from 4 to 26 mN/m (onset after approximately 2 h)
but a similar Dp, 22 mN/m. With anionic lipids present
(DMPC/DMPS), HbCO injection resulted an increase in
surface pressure that was both faster and larger (from 0 to 30
mN/m, Dp = 30 mN/m). On this timescale (10 h), change in
monolayer surface pressure due to evaporation was not
observed. On a timescale of less than 15 min, HbCO
showed surface activity only when anionic lipids were
present (DMPC/DMPS or DMPC/DMPG).
3.2. Effect of solution ionic strength and pH on surface
pressure (HBCO)
The contribution of HbCO to the surface pressure of a
monolayer containing DMPC/DMPS/Dchol (3:3:2) de-
creases with ionic strength of subphase, as shown in Fig.
2. Fig. 3 illustrates that HbCO increased surface activity at
low pH and decreased surface activity at high pH.
3.3. Kinetics of increasing surface pressure (HBCO)
Values of surface pressure vs. time were fit to the
following stretched exponential equation:
pt ¼ pl  p0eðktÞ
b ð1Þ
where pt is the monolayer pressure at time t, pl is the
equilibrium monolayer pressure, p0 is the initial monolayer
pressure, k is the rate coefficient, and b is an exponential
scaling factor. The choice of equations is explained in the
discussion section. For monolayers containing HbCO,
Figs. 4 and 5 show the relationship between pH of a
subphase containing 5 mM phosphate and either k or b,
respectively.
3.4. Effect of solution viscosity on surface pressure (HBCO)
If the transport of HbCO is diffusion-limited, it is
reasonable to expect that the rate of increase of surface
pressure is affected by the addition of dextran to alter the
viscosity of the subphase solution. Dextran had no surface
activity at concentrations less than 5 mg/ml (viscosity less
than 1.12 Cp). Higher dextran concentrations of 10–100
mg/ml (viscosities 1.25–3.0 Cp) had no surface activity at
short time scales of less than 15 min (data not shown).
Rate coefficients were fit to a power curve (data not
shown).
Fig. 2. Monolayer pressure, p, vs. time, 167 nM HbCO subphase,
DMPC/DMPS/DChol (3:3:2) monolayer. Data are for different subphase
ionic strengths: ( ) water; ( w ) 5 mM phosphate; (5) PBS. Rate
coefficients were found to be 0.0132F 0.0032, 0.00213F 1.9e 4, and
7.07e 4F 1.8e 4 s 1 for water, 5 mM phosphate, and PBS, res-
pectively.
Fig. 3. Monolayer pressure, p, vs. time, 167 nM HbCO in 5 mM phosphate
buffer subphase, DMPC/DMPS (50:50) monolayer. Data are for different
subphase pH values: (5) pH 6.4; ( ) pH 7.4; ( w ) pH 8.4.
Fig. 4. Rate coefficient, k, vs. pH, 167 nM HbCO in 5 mM phosphate buffer
subphase, DMPC/DMPS (50:50) monolayer.
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3.5. GAPDH surface activity in the presence/absence of
lipids
As with HbCO, the injection of GAPDH (final concen-
tration of 167nM) into the aqueous subphase of the trough
produces an increase in surface pressure from 0 to 22 mN/m
even in the absence of lipids, as shown in Fig. 6. Addition of
cationic lipids (DMPC/DMetPC), unchanged lipids
(DMPC), and anionic lipids (DMPC/DMPS) results in
successively higher values of surface pressure (Dp = 21,
25, and 27 mN/m, respectively) and generally faster
increases.
3.6. Effects of ionic strength and pH on GAPDH–
monolayer interaction
In systems of higher subphase ionic strength (PBS, 150
mM salt), injection of GAPDH into the subphase resulted in
immediate surface activity. For all systems, with or without
lipids present, Dp was 18 mN/m. Systems without lipids,
with neutral lipids (DMPC), or with cationic lipids (DMPC/
DMetPC) had rate coefficients of approximately 0.022 s 1.
Systems with anionic lipids (DMPC/DMPS) had a faster
increase in surface pressure, with a rate coefficient of 0.031
s 1. These results are illustrated in Fig. 7 and summarized
in Table 1.
Injection of GAPDH into a PBS subphase of a DMPC/
DMPS monolayer resulted in the same Dp, 18 mN/m,
whether of the subphase pH 6.4, 7.4, or 8.4 (Fig. 8). The
rate coefficient for the GAPDH–monolayer interaction was
also the same (within errors for the fits) for all three
subphase pH values.
3.7. Kinetics
Data for the increase in surface pressure due to
GAPDH vs. time were fit to the same equation (Eq. (1))
Fig. 6. Monolayer pressure, p, vs. time, GAPDH injected into 5 mM
phosphate buffer subphase (final protein concentration 167 nM). Data are
for different monolayer compositions: ( ) DMPC/DMPS; (+) DMPC; ( w )
DMPC/DMetPC; (5) no lipids present.
Fig. 7. Monolayer pressure, p, vs. time, GAPDH injected into PBS
subphase (final protein concentration 167 nM). Data are for different
monolayer compositions: ( ) DMPC/DMPS; (+) DMPC; ( w ) DMPC/
DMetPC; (5) no lipids present.
Table 1
Rate coefficients and b values for fit of surface pressure vs. time of GAPDH
in PBS subphase
Monolayer lipid composition k (s 1) b
No lipids 0.021F 0.004 0.42F 0.04
DMPC 0.022F 0.001 0.61F 0.03
DMPC/DMPS 0.031F 0.002 0.71F 0.04
DMPC/DMetPC 0.023F 0.002 0.62F 0.03
Fig. 5. b vs. pH, 167 nM HbCO in 5 mM phosphate buffer subphase,
DMPC/DMPS (50:50) monolayer.
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as data for HbCO. Rate coefficients and b values are
shown in Table 1.
3.8. Surface activity of polyhistidine
Polyhistidine (poly-L-histidine, average molecular
weight 15,800) injected into the subphase at a final con-
centration of 5 AM does not show surface activity in the
absence of lipids at the air–water interface. When anionic
lipids (DMPC/DMPS) are deposited on the surface, surface
pressure increases. Figs. 9 and 10 illustrate this for sub-
phases containing low and high ionic concentrations,
respectively. At low ionic strength (5 mM phosphate
buffer), and pH 7.4 or 8.4, surface pressure increased from
approximately 5 to 9 mN/m over the course of hours. At
lower pH of 6.4 surface pressure increases further from
approximately 8 to 16 mN/m over several hours. At high
ionic strength (PBS), the situation is nearly repeated except
that at pH 6.4, a higher surface pressure (19 mN/m) is
reached in a shorter time.
4. Discussion
Studies of HbCO with lipid monolayers at the air–water
interface indicate that the interaction between HbCO and
surface is primarily electrostatic. Although HbCO shows
surface activity when no lipids are present, it shows the
greatest surface activity in the presence of phosphatidylser-
ine (PS), which is negatively charged. Surface activity is
observed on timescales of less than 15 min only when PS is
present in the monolayer. Furthermore, HbCO surface
activity decreases with increasing subphase ionic strength.
Increasing ionic strength from 0 mM (water) to 5 mM
results in a fivefold decrease in rate, while increasing ionic
strength to 150 mM (PBS) results in a further threefold
decrease in rate. The increase in surface activity of HbCO
with decreasing pH is likely due to the titration of amino
acid residues (namely histidine) in HbCO. The aqueous
phase isoelectric point of Hb is 7.1. Fig. 4 shows a
significant change in rate of monolayer interaction around
that pH. The best fit (coefficient of determination, R2 = 1.0)
could be obtained only by fitting two lines to the data; a line
fit through the slope of the data (rate coefficient vs. pH)
yields a slope of  8.8 10 3 for pH values less than 7.2,
while for pH values greater than 7.4 the slope is an order of
magnitude smaller (slope = 6.8 10 4). Similar behavior
is seen in Fig. 5, where b is in the range of 0.5–0.6 for pH
values less than 7.3 and is 0.9–1.4 for pH values of 7.3 and
Fig. 9. Monolayer pressure, p, vs. time, polyhistidine injected into 5 mM
phosphate buffer subphase (final protein concentration 5 AM), DMPC/
DMPS (50:50) monolayer. Data are for subphase pH values: ( w ) pH 6.4;
(5) pH 7.4; ( ) pH 8.4.
Fig. 10. Monolayer pressure, p, vs. time, polyhistidine injected into PBS
subphase (final protein concentration 5 AM), DMPC/DMPS (50:50)
monolayer. Data are for subphase pH values: ( w ) pH 6.4; (5) pH 7.4;
( ) pH 8.4.
Fig. 8. Monolayer pressure, p, vs. time, GAPDH injected into PBS
subphase (final protein concentration 167 nM), DMPC/DMPS (50:50)
monolayer. Data are for subphase pH values: ( ) pH 6.4; (+) pH 7.4; (5)
pH 8.4.
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greater. Below the isoelectric point, HbCO has a net positive
charge, making electrostatic interactions with the negatively
charged PS headgroup probable. Even above the pI, where
HbCO should have a net negative charge, some amino acid
residues may still carry positive charges. These findings are
consistent with reports of other proteins shown to interact
with lipid monolayers in a predominantly electrostatic
manner, including myelin h-lactoglobulin [14] and GM2-
activator protein [15].
The rate constants extracted from the fit of surface
pressure vs. time to a stretched exponential equation (Eq.
(1)) can be used to learn about the process by which HbCO
approaches the air–water interface. An exponential scaling
factor b = 0.5 is indicative of a diffusion-limited process. In
the protein–lipid monolayer system, such kinetics would
describe a protein molecule undergoing a random walk
through the subphase with some fraction of walks ending
at the air–water interface. When b = 1, first-order kinetics
are obtained. Values of b greater than 1 do not correspond to
known physical processes and it is unknown why values of
b > 1 are found [16,17].
Stretched exponential kinetics have been studied previ-
ously for various model systems of molecules at surfaces
[18,19] including uncharged polymers at solid–liquid and
liquid– liquid interfaces [20,21], polyelectrolytes at the
solid–liquid interface [22,23], and proteins at the solid–
liquid interface [24,25]. Stretched exponential kinetics have
also been used to describe chemical and physical rate
processes in disordered media, including protein–ligand
interactions, reaction kinetics of biopolymers, and the stat-
istical distributions of open and closed times of ion channels
[17]. Diffusion-limited reactions describe a wide variety of
systems, even those involving charged polymers (or pro-
teins) and charged surfaces.
If the transport of HbCO to the lipid surface is diffusion-
limited, the rate coefficient, k, should be proportional to the
diffusion coefficient of HbCO and thus, according to the
Stokes–Einstein equation [26], inversely proportional to the
viscosity of the subphase such that k = c/g. This prediction
was tested by altering subphase viscosity, g, via addition of
dextran. Microscopic viscosity (on the scale of HbCO
molecules) was assumed to be the same as macroscopic
viscosity, since the experiment used dextran with an average
molecular weight of 70,000, which is approximately the
same size as HbCO. Data fit to a power curve showed an
inverse relationship between rate coefficient and viscosity,
though scatter in the data prohibited quantitation of this
inverse relationship (i.e., fits ranging from k= c/g to k = c/g4
could not be differentiated).
The surface activity of GAPDH is less dependent on
electrostatic interactions than HbCO, as shown. The rate of
surface pressure increase due to GAPDH was slightly higher
when the lipid monolayer contained negatively charged PS.
However, Fig. 8 shows that a change in pH from 6.4 to 8.4
does not affect the rate of increase of surface pressure. Using
subphase of PBS rather than low ionic strength 5 mM
phosphate, the final surface pressure was independent of
which lipids were in the monolayer. Also, the rate of surface
pressure increase was much faster with PBS. This could be
due to a ‘‘salting-out’’ effect such that in an increasingly
ionic environment the largely hydrophobic GAPDH goes to
the hydrophobic air–water interface. This result is in con-
trast to that observed with HbCO, where the presence of
additional ionic species in solution screens the protein–lipid
interaction. The combination of these results indicates that
although there is an electrostatic component to the
GAPDH–lipid interaction, there is also a significant hydro-
phobic component. Studies of other protein–monolayer
systems suggest that the combined electrostatic and hydro-
phobic interaction is reasonable [27–30].
The pressure–time data for the GAPDH–lipid interac-
tion were fit to the same stretched exponential equation (Eq.
(1)) as the data for the HbCO–lipid interaction. As Table 1
shows, b is slightly higher (0.71F 0.04) at DMPC/DMPS
monolayer vs. other lipid monolayer systems. The DMPC/
DMPS system may deviate more from the diffusion-limited
model (b = 0.5) due to electrostatic interactions between the
PS headgroup and GAPDH. When no lipids are present
(b = 0.42F 0.04) the system behaves closest to the diffu-
sion-limited model of b = 0.5.
The polyhistidine–lipid monolayer interaction is almost
entirely electrostatic. In the absence of a lipid monolayer,
polyhistidine shows no surface activity, even at protein
concentrations 30 times that used for the HbCO and
GAPDH studies. Even in the presence of a DMPC/DMPS
monolayer, there was little increase in surface pressure.
Only at pH 6.4, where polyhistidine would have a larger
positive charge, does the surface pressure increase more
than 4 mN/m. This result is consistent with previous studies
of other polypeptides [31,32]. Despite the results above,
increasing salt concentration does not diminish the observed
surface pressure as expected for an electrostatic interaction
and as seen previously with HbCO. There is likely a small
hydrophobic component to the polyhistidine–lipid interac-
tion, even though electrostatic forces dominate.
In summary, the basic studies presented here provide
insight into the relative weight of electrostatic vs. hydro-
phobic interactions of nominally soluble proteins with lipid
monolayers at the air–water interface, though more sophis-
ticated studies are needed to understand all aspects of the
protein–lipid interactions. The results presented here show
that HbCO has a largely electrostatic interaction with lipid
monolayers that increases with decreasing pH and can be
screened by increasing ionic strength of the subphase. In
contrast, the GAPDH–lipid monolayer interaction is largely
hydrophobic rather than electrostatic. Although GAPDH has
the greatest interaction with PC/PS monolayers, the differ-
ence compared to other monolayer compositions is not as
great as with HbCO. With PBS in the subphase, monolayer
lipid composition and pH do not affect the change in surface
pressure, Dp. Polyhistidine is more like HbCO in that there
is a primarily electrostatic component in its interaction with
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lipid monolayers, as seen in the pH dependence of the
interaction. The hydrophobic component of the polyhisti-
dine–lipid monolayer interaction is likely small, as (unlike
HbCO or GAPDH) polyhistidine does not show surface
activity in the absence of lipids.
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